.RESEARCH FEATURE.06 August 2024.
A huge randomized regulated trial along with cisgender females highlights the difficulties of adherence to a regular dental preexposure prophylaxis regiment and demonstrates that twice-yearly treatment of lenacapavir can keep successful HIV protection amounts over 6 months.